Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS

被引:11
|
作者
Saposnik, Gustavo [1 ,2 ,3 ]
Maurino, Jorge [4 ]
Sempere, Angel P. [5 ]
Ruff, Christian C. [2 ]
Tobler, Philippe N. [2 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med, Div Neurol, 55 Queen St East, Toronto, ON M5C 1R6, Canada
[2] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland
[3] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
[4] Roche Farma, Dept Med, Neurosci Area, Madrid, Spain
[5] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain
来源
基金
瑞士国家科学基金会;
关键词
multiple sclerosis; herding; disease-modifying therapy; neuroeconomics; decision-making; risk aversion; SOCIAL-INFLUENCE; INTERFERON-BETA; MANAGEMENT; RISK; MRI;
D O I
10.2147/PPA.S124192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Herding is a phenomenon by which individuals follow the behavior of others rather than deciding independently on the basis of their own private information. A herding-like phenomenon can occur in multiple sclerosis (MS) when a neurologist follows a therapeutic recommendation by a colleague even though it is not supported by best practice clinical guidelines. Limited information is currently available on the role of herding in medical care. The objective of this study was to determine the prevalence (and its associated factors) of herding in the management of MS. Methods: We conducted a study among neurologists with expertise in MS care throughout Spain. Participants answered questions regarding the management of 20 case scenarios commonly encountered in clinical practice and completed 3 surveys and 4 experimental paradigms based on behavioral economics. The herding experiment consisted of a case scenario of a 40-year-old woman who has been stable for 3 years on subcutaneous interferon and developed a self-limited neurological event. There were no new magnetic resonance imaging (MRI) lesions. Her neurological examination and disability scores were unchanged. She was advised by an MS neurologist to switch from interferon to fingolimod against best practice guidelines. Multivariable logistic regression analysis was conducted to evaluate factors associated with herding. Results: Out of 161 neurologists who were invited to participate, 96 completed the study (response rate: 60%). Herding was present in 75 (78.1%), having a similar prevalence in MS experts and general neurologists (68.8% vs 82.8%; P=0.12). In multivariate analyses, the number of MS patients seen per week was positively associated with herding (odds ratio [OR] 1.08, 95% CI 1.01-1.14). Conversely, physician's age, gender, years of practice, setting of practice, or risk preferences were not associated with herding. Conclusion: Herding was a common phenomenon affecting nearly 8 out of 10 neurologists caring for MS patients. Herding may affect medical decisions and lead to poorer outcomes in the management of MS.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [31] Lessons learned from Evidence-Informed Decision-Making in Nutrition & Health (EVIDENT) in Africa: a project evaluation
    Motani, Pankti
    Van de Walle, Anais
    Aryeetey, Richmond
    Verstraeten, Roosmarijn
    HEALTH RESEARCH POLICY AND SYSTEMS, 2019, 17 (1)
  • [32] Rapid production of pharmacoepidemiology results to inform regulatory decision-making: Lessons learned from the COVID-19 pandemic
    Lane, Samantha
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 197 - 198
  • [33] Lessons learned from a case of placenta previa totalis complicated by placenta accreta spectrum: Importance of timely decision-making
    Fathallah, Ibrahim
    Qatza, Ayham
    Alajrd, Abd Alrhman
    Al-Ali, Majd
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2025, 126
  • [34] The Standard of Care and conflicts at the End of Life in critical care: Lessons from medical-legal crossroads and the role of a quasi-judicial tribunal in decision-making
    Hawryluck, Laura
    Sibbald, Robert
    Chidwick, Paula
    JOURNAL OF CRITICAL CARE, 2013, 28 (06) : 1055 - 1061
  • [35] Abortions - Decision-Making Processes and Experiences with Psychosocial and Medical Care from the Perspective of Young Women
    Boehm, Maika
    ZEITSCHRIFT FUR SEXUALFORSCHUNG, 2020, 33 (03): : 125 - 133
  • [36] Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient Perspectives
    Visser, L. A.
    De Mul, M.
    Redekop, W. K.
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 927 - 937
  • [37] A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS)
    van Capelle, Archibald de Ceuninck
    van der Meide, Hanneke
    Vosman, Frans J. H.
    Visser, Leo. H.
    PLOS ONE, 2017, 12 (08):
  • [38] Decision-Making in the Era of New Medical Technologies in Pediatric Hematology-Oncology: The Death of Palliative Care?
    Fortin, Sylvie
    Le Gall, Josiane
    Richer, Johanne
    Payot, Antoine
    Duval, Michel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : 271 - 276
  • [39] Family Consent in Medical Decision-Making in Taiwan: The Implications of the New Revisions of the Hospice Palliative Care Act
    Lee, Shui Chuen
    FAMILY-ORIENTED INFORMED CONSENT: EAST ASIAN AND AMERICAN PERSPECTIVES, 2015, 121 : 125 - 136
  • [40] Introducing new vaccines: Challenges of decision making and lessons learned from the recent Hib vaccine introduction experience
    Hajjeh, R. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 50 - 50